Register entry
Chemical & Biopharmaceutical Laboratories of Patras Single Member S.A.
Data as of · How to read this entry
- Registered sites
- 1
- Active NDC listings
- 1
- Live patents
- 0
- Countries
- 1
- Base
- Greece
Authorisation
Registered operations
Analytical testing1Active ingredient (API) manufacture1Labelling1Packaging1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Chemical & Biopharmaceutical Laboratories of Patras Single Member S.A. | Industrial Area, Building Block 1, Patras, Achaia 25018, Greece (GRC) | Analytical testing, Active ingredient (API) manufacture, Labelling, Packaging | 3003474911499349970 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Octreotide acetate | powder | 84147-001BULK INGREDIENT |
Compare
Comparable companies in Greece
- BOEHRINGER INGELHEIM HELLAS SINGLE MEMBER S.A.1 site · 2 NDC
- Pharmathen International S.A.2 sites · 0 NDC
Enquiry
Common questions
- Is Chemical & Biopharmaceutical Laboratories of Patras Single Member S.A. FDA approved?
- Chemical & Biopharmaceutical Laboratories of Patras Single Member S.A. holds 1 FDA-registered establishment in Greece. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Chemical & Biopharmaceutical Laboratories of Patras Single Member S.A.'s drugs manufactured?
- The FDA register lists Patras. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, packaging.
- What drugs does Chemical & Biopharmaceutical Laboratories of Patras Single Member S.A. make?
- 1 product is listed under Chemical & Biopharmaceutical Laboratories of Patras Single Member S.A. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.